A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)

NCT04306887 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)

Interventions

DRUG: TQ-B3101 capsule

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.